Pelagos Insurance
PLGO
23.81
+0.04
+0.17%
Pelagos Insurance
US · PLGO
#2767 by market cap
Listed 2023
23.81
+0.04
+0.17%
Live - 5344 symbols - heartbeat 449s ago
· 2026-10-07 19:54
After-hours
23.81
0.00%
- Market cap
- 1.97B
- P/E (TTM)i
- 5.91
- P/Bi
- 0.89
- EPSi
- 2.11
- Div yieldi
- 2.52%
- 52W posi
- 74%
Reader sentiment
Are you bullish or bearish on PLGO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.5 percentage points.
Institutional ownership
- Held by institutions
- 92.75% -0.53pp
- Institutions
- 237 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund31.41%
VC/PE Fund24.20%
Hedge Fund16.04%
Private Company11.02%
Public Company8.77%
Individual/Insider1.18%
Government Pension Fund0.61%
Insurance Company0.49%
Family Office/Trust0.19%
Other6.09%
Top holders as of 2026-06-30
Crestview Advisors, L.L.C.
17.23% · 14.25M sh
TFP Group Limited
10.31% · 8.53M sh
Omega Advisors, Inc.
10.18% · 8.42M sh
The Travelers Companies, Inc.
7.02% · 5.81M sh
Pine Brook Road Partners, LLC
6.97% · 5.77M sh
LSV Asset Management
5.76% · 4.76M sh
Dimensional Fund Advisors
3.91% · 3.23M sh
BlackRock
3.72% · 3.08M sh
American Century Investment Management
1.81% · 1.50M sh
Bridgeway Capital Management, LLC
1.41% · 1.17M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
33 filings tracked · 11 buys · 8 sells
| Name | Role | Stake |
|---|---|---|
| Crestview Advisors, L.L.C. | -- | 17.23% |
| Daniel Burrows | Chief Executive Officer | 0.51% |
| Michael Pearson | Chief Risk Officer | 0.14% |
| Allan Decleir | Chief Financial Officer | 0.12% |
| Charles Mathias | Director | 0.12% |
| Jonathan Strickle | Group Chief Actuarial Officer | 0.02% |
| Cathy Iberg | Independent Non-Executive Director | 0.02% |
| Matthew Adams | Director | 0.02% |
| Christine Dandridge | Director | 0.02% |
| Daniel Kilpatrick | Independent Non-Executive Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-13 | Michael Davern | Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-06-02 | Jonathan Strickle | Group Chief Actuarial Officer | Sale to Issuer | -2,881 | $21.58 |
| 2026-03-29 | Christine Dandridge | Director | Other Acquisition | +6,517 | -- |
| 2026-03-29 | Helena Morrissey | Independent Non-Executive Chairperson | Other Acquisition | +7,820 | -- |
| 2026-03-29 | Charles Collis | Independent Non-Executive Director | Other Acquisition | +6,517 | -- |
| 2026-03-29 | Cathy Iberg | Independent Non-Executive Director | Other Acquisition | +6,517 | -- |
| 2026-03-29 | Allan Decleir | Chief Financial Officer | Other Acquisition | +19,520 | -- |
| 2026-03-29 | Daniel Burrows | Chief Executive Officer | Other Acquisition | +154,170 | -- |
| 2026-03-29 | Michael Pearson | Chief Risk Officer | Other Acquisition | +33,107 | -- |
| 2026-03-29 | Jonathan Strickle | Group Chief Actuarial Officer | Other Acquisition | +71,725 | -- |
| 2026-03-29 | Matthew Adams | Director | Other Acquisition | +6,517 | -- |
| 2026-03-29 | Jason Kittinger | Group Chief Operating Officer | Other Acquisition | +37,682 | -- |
| 2026-03-29 | Nicole Kapu-Leyland | Group General Counsel | Other Acquisition | +46,376 | -- |
| 2026-03-17 | Christine Dandridge | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Charles Collis | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Cathy Iberg | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Charles Mathias | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Allan Decleir | Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Daniel Kilpatrick | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Daniel Burrows | Chief Executive Officer | Initial Statement of Beneficial | 0 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.